Table 3.

Long non-coding RNAs previously reported as differentially expressed in prostate cancer.

Gene type	Gene	Probe set ID	Comparison	t-Test p-value	MFD ratio	Reference
LncRNA	ANRIL	3165014	Primary vs. normal	<0.01	−1.17	Yap et al. (2010)
		3165015	Metastatic vs. normal	<0.01	1.49
		3165015	Metastatic vs. primary	<0.02	1.33
	H19	3359101	Primary vs. normal	<0.01	1.32	Berteaux et al. (2004)
		3359097	Metastatic vs. normal	<0.01	1.43
		3359095	Metastatic vs. primary	<0.01	−1.12
	PCA3	3175541	Primary vs. normal	<0.01	14.3	Bussemakers et al. (1999)
		3175545	Metastatic vs. normal	<0.01	4.46
		3175541	Metastatic vs. primary	<0.01	−3.44
	MALAT1	3335195	Primary vs. normal	<0.01	−1.64	Lin et al. (2007)
		3335195	Metastatic vs. normal	<0.01	−3.33
		3335195	Metastatic vs. primary	<0.01	−2.63
	PCGEM1	2520747	Primary vs. normal	<0.01	1.75	Srikantan et al. (2000)
		2520749	Metastatic vs. normal	<0.2	−1.58
		2520749	Metastatic vs. primary	<0.01	−4.00
	PTENP1	3203669	Primary vs. normal	<0.01	−1.34	Poliseno et al. (2010)
		3203666	Metastatic vs. normal	<0.6	−1.09
		3203669	Metastatic vs. primary	<0.04	1.50
miRNA	MIR143	2835118	Metastatic vs. primary	<0.01	−1.78	Clape et al. (2009)
	MIR145	2835126	Metastatic vs. primary	<0.01	−4.77	Zaman et al. (2010)
		2835126	Metastatic vs. normal	<0.01	−7.98
	MIR221	4006597	Metastatic vs. primary	<0.01	−1.52	Porkka et al. (2007)
		4006597	Metastatic vs. normal	<0.01	−2.11

MFD: median fold difference in this dataset in various comparisons. The MFD value is computed as the ratio of the median between the first tissue type and the second tissue type in the “Comparison” column. Gray cells indicate statistical significance after multiple testing correction. Genes PCAT-1 (Prensner et al., 2011) and PRNCR1 (Chung et al., 2011) are not included as there is no gene model associated.